Silencing of Kinesin Light Chain 1 Suppresses Aggressive Phenotypes in Cholangiocarcinoma Cells Through Transcriptomic Alterations
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177525 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Thanakrit Rattanaarchanai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, Prince of Songkla University, Hat Yai 90110, Songkhla, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Microtubule-Associated Proteins, Transcriptome. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prince of Songkla University, National Science, Research and Innovation Fund.
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) is an aggressive malignancy with limited treatment options and poor clinical outcomes. Kinesin light chain 1 (KLC1), a component of the kinesin-1 motor complex involved in intracellular transport, has been implicated in cancer biology; however, its role in CCA remains unclear. This study investigated the functional role and molecular alterations associated with KLC1 silencing in CCA. Analysis of publicly available datasets showed that KLC1 mRNA expression was significantly elevated in CCA tissues, and immunohistochemical images from the Human Protein Atlas demonstrated stronger KLC1 protein expression in tumor tissues. siRNA-mediated KLC1 knockdown markedly suppressed cell proliferation, migration, and invasion in KKU-213A and KKU-055 cells and altered the expression of epithelial–mesenchymal transition-associated proteins. Transcriptomic profiling identified 2074 differentially expressed genes following KLC1 knockdown. Functional enrichment analyses revealed significant alterations in cytoskeleton-associated processes and mitogen-activated protein kinase (MAPK) signaling. Protein–protein interaction network analysis identified interconnected gene networks associated with these pathways. Selected differentially expressed genes were validated by RT–qPCR, supporting the transcriptomic findings. Collectively, these results suggest that KLC1 contributes to aggressive phenotypes in CCA cells and is associated with transcriptomic alterations involving cytoskeletal regulation and MAPK signaling, highlighting KLC1 as a potential contributor to CCA progression and warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, Prince of Songkla University, Hat Yai 90110, Songkhla, Thailand.
- Center of Excellence for Biochemistry, Faculty of Science, Prince of Songkla University, Hat Yai 90110, Songkhla, Thailand.
ORCID-Profile: Thanakrit Rattanaarchanai, Phanthipha Runsaeng, Sompop Saeheng, Sumalee Obchoei
Förderung
- Prince of Songkla University
- National Science, Research and Innovation Fund
Zitieren
APA
Rattanaarchanai, T., Tantimetta, P., Runsaeng, P., Saeheng, S., & Obchoei, S. (2026). Silencing of Kinesin Light Chain 1 Suppresses Aggressive Phenotypes in Cholangiocarcinoma Cells Through Transcriptomic Alterations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177525
Vancouver
Rattanaarchanai T, Tantimetta P, Runsaeng P, Saeheng S, Obchoei S. Silencing of Kinesin Light Chain 1 Suppresses Aggressive Phenotypes in Cholangiocarcinoma Cells Through Transcriptomic Alterations. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177525
BibTeX
@article{Rattanaarchanai2026,
author = {Rattanaarchanai, Thanakrit and Tantimetta, Phonprapavee and Runsaeng, Phanthipha and Saeheng, Sompop and Obchoei, Sumalee},
title = {Silencing of Kinesin Light Chain 1 Suppresses Aggressive Phenotypes in Cholangiocarcinoma Cells Through Transcriptomic Alterations},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177525}
}
EUVIMED